ArticleClinical lung cancer2026
Effects of Sex on Mortality in Patients With Lung Cancer: A Multiple Mediation Analysis of The Boston Lung Cancer Study.
Article in Clinical lung cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveIdentify the specific variables that can explain the sex difference in lung cancer mortality. MATERIAL AND
methodsThis retrospective cohort study analyzed data from the Boston Lung Cancer Study (1992-2022). We employed descriptive statistics, Wilcoxon rank-sum test, and Pearson's Chi-square test to compare demographic and clinical variables by sex. Kaplan-Meier survival curves and Cox proportional hazards models were used to evaluate survival differences. Mediation analysis was conducted to investigate causal pathways through which sex influences mortality, incorporating cancer stage, smoking status, and treatment modalities.
resultsAmong 7642 patients, 53.7% were women. Men were older, had heavier smoking histories, and more frequently received chemotherapy and radiotherapy, whereas women underwent more surgeries. Median survival was significantly longer for women (4.54 vs. 2.59 years), with a 29% reduced hazard of lung cancer-related death (HR: 0.71; 95% CI, 0.66-0.75; P < .0001). Approximately 32% of this survival difference was mediated by early-stage diagnosis, surgical intervention, and smoking history.
conclusionWomen exhibited a survival advantage, of which only about one-third was explained by earlier diagnosis and higher surgical intervention rates. The remaining two-thirds of the mortality difference remains unexplained. Addressing these modifiable factors may reduce sex inequalities in lung cancer outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.